Evidence map›Paper›PMID 41641291›Full record

ArticleAACE endocrinology and diabetes

Anaplastic Thyroid Carcinoma With Horner Syndrome and Unusual Metastasis Reveals Masked Papillary Thyroid Carcinoma Following Neoadjuvant Therapy.

Zain Akhtar, Humberto López Castillo, Deepa Taneja

Abstract readCase Reports
In one paragraph

Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zain AkhtarBurnett School of Biomedical Sciences, College of Medicine, Academic Health Sciences Center, University of Central Florida, Orlando, Florida.
Humberto López CastilloDepartment of Health Sciences, College of Health Professions and Sciences, Academic Health Sciences Center, University of Central Florida, Orlando, Florida.
Deepa TanejaFlorida Diabetes, Thyroid, and Endocrine Center, Orlando, Florida.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Objective: Anaplastic thyroid carcinoma (ATC) is a rare thyroid cancer that has the propensity to be hyperactive and is characterized by the dedifferentiation of follicular cells leading to pleomorphism. This report highlights a 68-year-old man's progression of ATC with an unusual presentation and secondary symptoms revealed to be masking an independent tumor cell origin residual papillary thyroid carcinoma following targeted treatment. Case Report: A 68-year-old man presenting with a history of aortic aneurysm and hyperlipidemia was referred for type 2 diabetes mellitus complications. He had a successful aneurysm repair; however, follow-up imaging revealed a thyroid mass, cystic lesions in the pancreas and liver, and extensive lymphadenopathy, and he endorsed symptoms of Horner syndrome. Fine-needle aspiration suggested ATC, and sequencing confirmed a Discussion: Normally, comorbid thyroid malignancies arise from identical follicular sequence variants. It is unusual to observe 2 independent origins from comorbid thyroid cancers. In addition, the development of Horner syndrome from thyroid cancer, especially anaplastic, is incredibly rare. Conclusion: This case is a unique depiction of how ATC can present despite uncharacteristic immunohistochemical markers, secondary symptoms, and hidden comorbidities. As an understudied malignancy, it is important to recognize this condition's variability to prevent increased mortality and morbidity.

Indexed as

anaplastic thyroid carcinomaHorner syndromeneoadjuvant therapypapillary thyroid cancerproto-oncogene proteins B-raf

Identifiers

PMID41641291
PMCPMC12866176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.